Carlos Escobar

ORCID: 0009-0003-7350-3098
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Venous Thromboembolism Diagnosis and Management
  • Hormonal Regulation and Hypertension
  • Lipoproteins and Cardiovascular Health
  • Cardiac pacing and defibrillation studies
  • Heart Rate Variability and Autonomic Control
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Sodium Intake and Health
  • Diabetes Treatment and Management
  • Cardiovascular Syncope and Autonomic Disorders
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Cardiac electrophysiology and arrhythmias
  • Cardiac, Anesthesia and Surgical Outcomes
  • Cardiac Health and Mental Health
  • Cardiac Imaging and Diagnostics
  • Medication Adherence and Compliance
  • Pharmacology and Obesity Treatment
  • Acute Myocardial Infarction Research
  • Chronic Kidney Disease and Diabetes
  • Pharmaceutical Practices and Patient Outcomes

Hospital Universitario La Paz
2016-2025

Hospital Prof. Dr. Fernando Fonseca
2013-2024

Administração Regional de Saúde de Lisboa e Vale do Tejo
2024

Keck Hospital of USC
2024

Centro de Investigación en Red en Enfermedades Cardiovasculares
2022

Instituto de Salud Pública de Chile
2021

Weatherford College
2007-2021

Flint Institute Of Arts
2021

Universidad Autónoma de Madrid
2020

Hospital Dr. Nélio Mendonça
2020

Hisham Dokainish Koon Teo Jun Zhu Ambuj Roy Khalid F. AlHabib and 95 more Ahmed ElSayed Lia Palileo-Villaneuva Patricio López‐Jaramillo Kamilu M. Karaye Khalid Yusoff Andrés Orlandini Karen Sliwa Charles Mondo Fernando Laņas Dorairaj Prabhakaran Amr Badr Mohamed ElMaghawry Albertino Damasceno Kemi Tibazarwa Emilie P. Belley‐Côté Kumar Balasubramanian Shofiqul Islam Magdi H. Yacoub Mark D. Huffman Karen Harkness Alex Grinvalds Robert S. McKelvie Shrikant I. Bangdiwala Salim Yusuf Ruy R. Campos Cecilia Chacón Guillermo Cursack Fabián Diez Carlos Escobar Carlos García Oscar Gómez Vilamajó Miguel Hominal Adrián Ingaramo G. Kucharczuk Mauricio Pelliza Angela Rosa Guitiérrez Rojas Alessandra Villani Gerardo Zapata Paula Bourke Fernando Laņas L. Nahuelpan Carlos Olivares R. Riquelme Fen Ai Xiuyuan Bai X. Chen Y. Chen Min Gao Chenliang Ge YANBIAO HE Wenjie Huang Hongqun Jiang Tuo Liang Xinling Liang Yuhua Liao S. Liu Yu Luo L. Lu Shengmei Qin Gabriel Tan Hua Tan T. Wang Xuchen Wang F.J. Wei Fei Xiao B. Zhang Tianheng Zheng J.L. Mendoza M. Blanquicett Anaya Efraín Gómez D.I. Molina de Salazar Franklin Quiroz M.J. Mota Rodríguez M. Suarez Sotomayor A. Torres Navas M. Bravo León Leilani Montalvo Mónica Jaramillo Emilia Patiño C Perugachi F. Trujillo Cruz Mohamed ElMaghawry Kerolos Wagdy Aishwarya Bhardwaj Vivek Chaturvedi G. Krishna Gokhale Rajeev Gupta R. Honnutagi Parag H. Joshi Shamez Ladhani Prakash Chand Negi Ambuj Roy Naveen Reddy Ahed Najimelddin Abdullah Mustafa Hassan

Most data on mortality and prognostic factors in patients with heart failure come from North America Europe, little information other regions. Here, the International Congestive Heart Failure (INTER-CHF) study, we aimed to measure at 1 year Africa, China, India, Middle East, southeast Asia South America; also explored demographic, clinical, socioeconomic variables associated mortality.We enrolled consecutive (3695 [66%] clinic outpatients, 2105 [34%] hospital patients) 108 centres six...

10.1016/s2214-109x(17)30196-1 article EN cc-by-nc-nd The Lancet Global Health 2017-05-03
Martín Ruiz Ortiz Javier Muñiz P Rana Miguez Inmaculada Roldán Francisco Marı́n and 95 more María Asunción Esteve‐Pastor Ángel Cequier Manuel Martínez‐Sellés Vicente Bertoméu Manuel Anguita Manuel Almendro Luis Alonso‐Pulpón Jorge Duerto Ignasi Anguera Manuel Anguita Jorge Arnulfo Alfredo Bardajı́ Gonzalo Barón‐Esquivias Antoni Bayés‐Genís Neus Bellera Vicente Bertomeu G. J L Bonilla Vicens Brossa Francisco Buendía Fuentes José Camacho Teresa Rodríguez Cano M.A. Martı́nez J García Casas Juan C. Castillo Marta Ma Cobo Inmaculada Coca Ingrid Colomer Josep Comín Luis Cornide Juan Cosín Manuel Crespín Crespín Pedro Chinchurreta David Chivite Tomás Datino Ramón de Castro José Gonzalo Delgado Mónica Delgado Mar Domingo Paloma Elviro Carlos Escobar Esther Esteban Fátima Esteban António Fernández Andrés López Fernández Enrique Galve José María Gámez Martínez Antonio Luis Gámez Daniel García Ana Maria Garcı́a María Laura García Lorena García Miguel García Pablo García‐Pavía Francisco J. García‐García M. Carmen Gil Diego Giménez J.J. Gávira Gómez Sílvia Gómez Carlos M. Travieso Manuel Gonzálvez Jesús Manuel Hernández Rafael Hidalgo Cristina Jiménez Javier Jiménez José Luis Lambert Manuel Penas Lado Mariano Leal Antonio Lillo Laura López José A. Madrigal Nicolás Manito Sergio Manzano Dolores Julia Yusá Marco Francisco Marín‐Ortuño Manuel Martínez‐Sellés Marta Mateos Rodrigo Mayo Pilar Mazón Jose A Niño Medina Javier Martínez Mesa Sònia Mirabet Ma Victoria Mogollón José Manuel Moreno Villares Nekane Murga Juana Núñez Carmen Olmos Imanol Otaegui Jaume Francisco‐Pascual Rafael Payá Alejandro Pérez J. Serna Pérez José Carlos Rodríguez Pérez José Carlos Rodríguez Pérez R Cabrera Pérez Neus Piulats

To describe the prevalence and associated factors of inappropriate doses direct oral anticoagulants (DOAC) in a national registry patients real clinical practice.Five hundred thirty outpatients with atrial fibrillation treated DOAC were included prospective, national, multicentre study. The appropriateness was defined according to recommendations European Heart Rhythm Association. Mean age 73 ± 9 years, 46% women. Two sixty-seven prescribed dabigatran, 190 rivaroxaban, apixaban. A total 172...

10.1093/europace/eux316 article EN EP Europace 2017-11-27

The assessment of risk and appropriate treatment patients with acute pulmonary embolism (PE) remains a challenge. prognostic performance cardiac troponin I (cTnI) in predicting 30-day all-cause mortality was prospectively assessed consecutive haemodynamically stable PE. present study included 318 During the period, 23 (7%) died. cTnI elevated (>or=0.1 ng x mL(-1)) 102 (32%) patients. An age >65 yrs, systolic blood pressure <120 mmHg severity illness using PE index (PESI) were significantly...

10.1183/09031936.00113307 article EN European Respiratory Journal 2007-12-20

Anti-idiotypic monoclonal antibody 409.5.3 is raised against an that neutralizes feline infectious peritonitis virus. This antibody, used as immunogen, elicits the production of anti-anti-idiotypic antibodies in turn neutralize The crystal structure complex between anti-idiotypic Fab and idiotypic fragment virus-neutralizing has been solved by molecular replacement using real-space Patterson search filtering correlation-coefficient refinement. refined to R value 0.21 based on 21,310 unique...

10.1073/pnas.91.5.1604 article EN Proceedings of the National Academy of Sciences 1994-03-01

To examine the evolution of hypertension management and blood pressure (BP) control in Spain last decade across PRESCAP 2002, 2006 2010.The methodology three studies was same. They were multicenter cross-sectional surveys aimed to determine BP rates hypertensive patients primary care during 2010, respectively. In each study, at least 18 years, with an established diagnosis included. Adequate defined as less than 140/90 mmHg general population (<130/85 2002 130/80 2010 for diabetes, chronic...

10.1097/hjh.0b013e3283592583 article EN Journal of Hypertension 2012-09-25

Despite steady improvements in cardiovascular disease (CVD) prevention, a scarce proportion of patients achieve the recommended LDL-C goals, even under high-intensity lipid-lowering therapy (LLT). Our study aimed to evaluate attainment rate targets by 2019 European guidelines, and characterize potential factors associated with goal achievement change patterns LLT. We conducted retrospective, observational on treated atorvastatin or rosuvastatin ± ezetimibe at cardiology internal medicine...

10.3390/jcm12093187 article EN Journal of Clinical Medicine 2023-04-28

We report the presence of SNPs in Plasmodium falciparum K13-propeller gene two African countries, Angola and Mozambique, where malaria is a serious public health problem. Samples were collected before after ACT introduction as first-line treatment. In each country 50 samples analysed. A total three different mutations (R471R R575R V494I Mozambique) identified five samples, all ACT. The R471R mutation detected has already been reported Africa (DR-Congo Gabon). However, (Angola) (Mozambique),...

10.1371/journal.pone.0119215 article EN cc-by PLoS ONE 2015-03-19
Anoopindar Bhalla Margaret J. Klein Vicent Modesto i Alapont Guillaume Émériaud Martin C. J. Kneyber and 95 more Alberto Medina Pablo Cruces Franco Díaz Muneyuki Takeuchi Aline B. Maddux Peter M. Mourani Cristina Camilo Benjamin R. White Nadir Yehya John Pappachan Matteo Di Nardo Steven L. Shein Christopher J. L. Newth Robinder G. Khemani Rossana Poterala Analía Fernández Antonio Ávila Vera Nilda Águeda Vidal Deheza Rosemary Gonzalo Turón Cecilia Monjes Alejandro Siaba Serrate Thomas Iölster Silvio Torres Pablo Castellani Martin Giampieri Claudia Pedraza Luis M. Landry María Althabe Yanina Vanesa Fortini Simon Erickson Samantha Barr Sara Shea Warwick Butt Carmel Delzoppo Alyssa Pintimalla Alejandro Fabio Martínez León Gustavo Alfredo Guzman Rivera Philippe Jouvet Guillaume Émériaud Mariana Dumitrascu Mary French Daniel Caro Carlos Acuña Franco Díaz Marı́a José Núñez Yang Chen Yurika Paola Lopez Alarcón Ledys Izquierdo Byron Enrique Piñeres-Olave Pablo Vásquez‐Hoyos Pierre Bourgoin Florent Baudin George Briassoulis Stavroula Ilia Matteo Di Nardo Fabrizio Chiusolo Nobuaki Shime Shinichiro Ohshimo Yoshiko Kida Michihito Kyo Swee Fong Tang Chian-Wern Tai Lucy Chai See Lum Ismail Elghuwael Carlos Escobar Marta Sousa Moniz Cristina Camilo Tarek Hazwani Nedaa Aldairi Ahmed Al Amoudi Ahmad Alahmadti Yolanda López Fernández Juan Ramón Valle Lidia Martinez J. Pilar Orive Vicent Modesto i Alapont M. Pons Alberto Medina Susana Reyes Oğuz Dursun Ebru Atike Ongun Füsun Can Ayşe Berna Anıl Jon Lillie Shane M. Tibby Paul Wellman Holly Belfield Joe Brierley Troy E. Dominguez Eugenia Abaleke Yael Feinstein James Weitz Peter‐Marc Fortune Gayathri Subramanian

Abstract Background Mechanical power is a composite variable for energy transmitted to the respiratory system over time that may better capture risk ventilator-induced lung injury than individual ventilator management components. We sought evaluate if mechanical ventilation with high associated fewer ventilator-free days (VFD) in children pediatric acute distress syndrome (PARDS). Methods Retrospective analysis of prospective observational international cohort study. Results There were 306...

10.1186/s13054-021-03853-6 article EN cc-by Critical Care 2022-01-03

Background: This analysis assesses the effectiveness and tolerability profile of vericiguat in patients with heart failure reduced ejection fraction (HFrEF) implantable cardioverter-defibrillator, an emphasis on emergence ventricular arrhythmias.

10.7573/dic.2024-10-5 article EN cc-by-nc-nd Drugs in Context 2025-03-05
Coming Soon ...